These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
640 related items for PubMed ID: 17337254
21. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta. Toba H, Miki S, Shimizu T, Yoshimura A, Inoue R, Sawai N, Tsukamoto R, Murakami M, Morita Y, Nakayama Y, Kobara M, Nakata T. Eur J Pharmacol; 2006 Nov 07; 549(1-3):124-32. PubMed ID: 16979161 [Abstract] [Full Text] [Related]
22. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice. Loffler M, Bilban M, Reimers M, Waldhäusl W, Stulnig TM. J Pharmacol Exp Ther; 2006 Feb 07; 316(2):797-804. PubMed ID: 16260581 [Abstract] [Full Text] [Related]
23. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Rong JX, Qiu Y, Hansen MK, Zhu L, Zhang V, Xie M, Okamoto Y, Mattie MD, Higashiyama H, Asano S, Strum JC, Ryan TE. Diabetes; 2007 Jul 07; 56(7):1751-60. PubMed ID: 17456854 [Abstract] [Full Text] [Related]
24. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Ellmark SH, Dusting GJ, Fui MN, Guzzo-Pernell N, Drummond GR. Cardiovasc Res; 2005 Feb 01; 65(2):495-504. PubMed ID: 15639489 [Abstract] [Full Text] [Related]
25. Mechanisms underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats. Matsumoto T, Noguchi E, Kobayashi T, Kamata K. Free Radic Biol Med; 2007 Apr 01; 42(7):993-1007. PubMed ID: 17349927 [Abstract] [Full Text] [Related]
26. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia. Berthiaume M, Laplante M, Tchernof A, Deshaies Y. Int J Obes (Lond); 2007 Nov 01; 31(11):1660-70. PubMed ID: 17579631 [Abstract] [Full Text] [Related]
27. Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Moore GB, Chapman H, Holder JC, Lister CA, Piercy V, Smith SA, Clapham JC. Biochem Biophys Res Commun; 2001 Aug 31; 286(4):735-41. PubMed ID: 11520059 [Abstract] [Full Text] [Related]
28. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Muranaka K, Yanagi Y, Tamaki Y, Usui T, Kubota N, Iriyama A, Terauchi Y, Kadowaki T, Araie M. Invest Ophthalmol Vis Sci; 2006 Oct 31; 47(10):4547-52. PubMed ID: 17003451 [Abstract] [Full Text] [Related]
29. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS, Chen WC, Bai X, Wang YD. J Dig Dis; 2007 May 31; 8(2):82-8. PubMed ID: 17532820 [Abstract] [Full Text] [Related]
30. Effect of rosiglitazone on the expression of cardiac adiponectin receptors and NADPH oxidase in type 2 diabetic rats. Guo Z, Qin Z, Zhang R, Li J, Yin Y. Eur J Pharmacol; 2012 Jun 15; 685(1-3):116-25. PubMed ID: 22542658 [Abstract] [Full Text] [Related]
31. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats. El Midaoui A, Wu L, Wang R, de Champlain J. Am J Hypertens; 2006 Apr 15; 19(4):407-12. PubMed ID: 16580578 [Abstract] [Full Text] [Related]
32. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway. Díaz-Delfín J, Morales M, Caelles C. Diabetes; 2007 Jul 15; 56(7):1865-71. PubMed ID: 17416798 [Abstract] [Full Text] [Related]
33. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production. Hoo RL, Chow WS, Yau MH, Xu A, Tso AW, Tse HF, Fong CH, Tam S, Chan L, Lam KS. Arterioscler Thromb Vasc Biol; 2007 Dec 15; 27(12):2777-82. PubMed ID: 17932317 [Abstract] [Full Text] [Related]
34. Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury. Qin HD, Huang D, Weng XD, Xu F. J Cell Physiol; 2009 Nov 15; 221(2):387-93. PubMed ID: 19562688 [Abstract] [Full Text] [Related]
35. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Guo Z, Su W, Allen S, Pang H, Daugherty A, Smart E, Gong MC. Cardiovasc Res; 2005 Sep 01; 67(4):723-35. PubMed ID: 15885672 [Abstract] [Full Text] [Related]
36. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property. Nam SM, Lee MY, Koh JH, Park JH, Shin JY, Shin YG, Koh SB, Lee EY, Chung CH. Diabetes Res Clin Pract; 2009 Feb 01; 83(2):176-82. PubMed ID: 19111363 [Abstract] [Full Text] [Related]
37. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism. Fuhrman B, Khateeb J, Shiner M, Nitzan O, Karry R, Volkova N, Aviram M. Arterioscler Thromb Vasc Biol; 2008 Jul 01; 28(7):1361-7. PubMed ID: 18436804 [Abstract] [Full Text] [Related]
39. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension. Fujii A, Nakano D, Katsuragi M, Ohkita M, Takaoka M, Ohno Y, Matsumura Y. Eur J Pharmacol; 2006 Dec 15; 552(1-3):131-4. PubMed ID: 17064681 [Abstract] [Full Text] [Related]
40. Relationship among superoxide-related enzyme, PPARs, and endothelium-dependent relaxation in murine aortas previously organ-cultured in high-glucose conditions. Takenouchi Y, Kobayashi T, Taguchi K, Matsumoto T, Kamata K. Can J Physiol Pharmacol; 2010 Jul 15; 88(7):760-9. PubMed ID: 20651824 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]